Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine Augmentation of CBT for Pediatric OCD
NCT00864123Phase 2
Key facts
- Status
- Completed
- Start
- Jan 2008
- Primary completion
- Nov 2009
- Countries
- 1
- Sponsor
- University of South Florida
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Drugs
- d-cycloserine
- Conditions
- obsessive compulsive disorder (OCD)
01
Overview
Phase 2, randomised, double-blind trial of d-cycloserine in obsessive compulsive disorder (OCD), sponsored by University of South Florida. Primary endpoint: Children's Yale-Brown Obsessive-Compulsive Scale. Started Jan 2008; status: completed.
02
Design
- Study design
- RandomizedDouble-blind
03
Who it enrols
Children 8-17 with a primary diagnosis of OCD (CY-BOCS >= 16) and weight 25-80kg. Excludes psychosis, bipolar disorder, pervasive developmental disorder, current suicidal intent, and those with mental rituals/hoarding.
04
Endpoints
Primary
Children's Yale-Brown Obsessive-Compulsive Scale
Secondary
Clinical Global Impression - Severity
Adverse Symptom Checklist
Beyond the preview
Go deeper on NCT00864123.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00864123.